Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 331.00M | $ 173.00M | $ 92.33M | $ 217.68M | $ 438.76M |
Total Assets | $ 3.75B | $ 3.64B | $ 3.56B | $ 3.36B | $ 3.65B |
Total Debt | $ 2.26B | $ 2.27B | $ 2.05B | $ 2.03B | $ 2.06B |
Net Debt | $ 1.93B | $ 2.09B | $ 1.96B | $ 1.81B | $ 1.63B |
Total Liabilities | $ 2.91B | $ 2.89B | $ 2.75B | $ 2.63B | $ 2.65B |
Stockholders Equity | $ 840.00M | $ 746.00M | $ 809.61M | $ 732.97M | $ 993.02M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |